Alterity Therapeutics (ATHE) Return on Capital Employed (2019)
Alterity Therapeutics' quarterly Return on Capital Employed came in at 136.03% in Q4 2019.
Alterity Therapeutics has reported Return on Capital Employed for 1 years, with the latest figure at 136.03% in Q4 2019.
- For the quarter ending Q4 2019, Return on Capital Employed changed N/A year-over-year to 136.03%; the trailing twelve-month figure through Dec 2019 stood at 136.03% (changed N/A YoY), and the FY2023 full-year result was 0.0%, up 3882.0% from the prior year.
- Return on Capital Employed for Q4 2019 stood at 136.03%.
- The five-year high for Return on Capital Employed was 136.03% in Q4 2019, with the low at 136.03% in Q4 2019.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 450.31% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 51.73% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -107.40% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 21.10% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 10.19% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 20.34% |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - | -21.94% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2019 | -136.03% |